SCHEMBL570241

SCHEMBL570241

O=Cc1nccnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29951770 1.00
SCHEMBL6852244 0.82 CCR1 (0.35)
SCHEMBL23457284 0.78
SCHEMBL13539865 0.76
SCHEMBL29280970 0.75
SCHEMBL18215464 0.72
SCHEMBL103808 0.71
SCHEMBL1134027 0.70
SCHEMBL376744 0.70 ALDH1A1 (0.33)
SCHEMBL5303261 0.70 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111892601-A Pyridopyrazolo cinnoline compound and preparation method and application thereof 朱继强 2020-11-06 CN claimed
EP-2336315-A2 Enzymatic encoding methods for efficient synthesis of large libraries Nuevolution A/S (DK) 2011-06-22 EP claimed
US-20250304537-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2025-10-02 US disclosed
CN-119894872-A Heteroarenes, pharmaceutical compositions containing heteroarenes, and methods of use thereof 修复治疗公司 2025-04-25 CN disclosed
EP-4526293-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Repare Therapeutics Inc. (CA) 2025-03-26 EP disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
US-20230416256-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARAMCEUTICA NV (BE) 2023-12-28 US disclosed
WO-2023220831-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2023-11-23 WO disclosed
CN-111132974-B Sulfonamide carboxamide compounds 英夫拉索姆有限公司 2023-11-21 CN disclosed
CN-111892601-B Pyridopyrazolocinnoline compound and preparation method and application thereof 陕西大美化工科技有限公司 2023-09-26 CN disclosed
US-20080275052-A1 HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2008-11-06 US disclosed
US-20080275052-A1 HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2008-11-06 US disclosed
US-20080275052-A1 HETEROBICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2008-11-06 US disclosed
EP-1957644-A2 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES Nuevolution A/S (DK) 2008-08-20 EP disclosed
WO-2007062664-A2 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES NUEVOLUTION A/S (DK) 2007-06-07 WO disclosed
EP-1295121-B1 A BIOLUMINESCENCE RESONANCE ENERGY TRANSFER (BRET) SYSTEM WITH BROAD SPECTRAL RESOLUTION BETWEEN DONOR AND ACCEPTOR EMISSION WAVELENGTHS AND ITS USE PERKINELMER BIOSIGNAL INC (CA) 2006-03-08 EP disclosed
US-20030203404-A1 Bioluminescence resonance energy transfer( bret) system with broad spectral resolution between donor and acceptor emission wavelengths and its use NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-10-30 US disclosed
EP-1295121-A1 A BIOLUMINESCENCE RESONANCE ENERGY TRANSFER (BRET) SYSTEM WITH BROAD SPECTRAL RESOLUTION BETWEEN DONOR AND ACCEPTOR EMISSION WAVELENGTHS AND ITS USE Biosignal Packard Inc. (CA) 2003-03-26 EP disclosed
WO-2001046691-A1 A BIOLUMINESCENCE RESONANCE ENERGY TRANSFER (BRET) SYSTEM WITH BROAD SPECTRAL RESOLUTION BETWEEN DONOR AND ACCEPTOR EMISSION WAVELENGTHS AND ITS USE BIOSIGNAL PACKARD INC. (CA) 2001-06-28 WO disclosed